Page 1 of Clinical Trials for Drug pegylated interferon-alpha-2a, 510 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin
Last Updated: April 30, 2012
Condition(s): Hepatitis C
2
Recruiting
Directly Observed Hepatitis C Treatment in Methadone Clinics
Last Updated: September 27, 2011
Condition(s): Hepatitis C; Medication Adherence
3
Active, not recruiting
Study of DEB025/Alisporivir Plus Pegylated Interferon alfa2a and Ribavirin and Boceprevir Plus Pegylated Interferon alfa2a and Ribavirin in African American Chronic Hepatitis C Genotype 1 Patients That Have Never Received Treatment for Their Hepatitis C
Last Updated: April 20, 2012
Condition(s): Hepatitis C; Liver Disease
4
Recruiting
Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)
Last Updated: February 29, 2012
Condition(s): High Risk Polycythemia Vera; High Risk Essential Thrombocythemia
5
Completed
A Study of HCV Polymerase Inhibitor Pro-Drug in Combination With PEGASYS With or Without COPEGUS in Patients With Chronic Hepatitis C Genotype 1 Infection.
Last Updated: July 4, 2011
Condition(s): Hepatitis C, Chronic
6
Recruiting
Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)
Last Updated: December 4, 2011
Condition(s): High Risk Polycythemia Vera; High Risk Essential Thrombocythemia
7
Active, not recruiting
A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C
Last Updated: November 7, 2011
Condition(s): Hepatitis C, Chronic
8
Completed
A Study of HCV Polymerase Inhibitor Pro-Drug in Combination With PEGASYS Plus COPEGUS Compared With PEGASYS Plus COPEGUS in Patients With Chronic Hepatitis C Genotype 1 Infection.
Last Updated: July 4, 2011
Condition(s): Hepatitis C, Chronic
9
Completed
Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C
Last Updated: December 17, 2007
Condition(s): Hepatitis C; Hepatitis
10
Recruiting
Pegylated Interferon, Ribavirin, Telaprevir in Hepatitis C Virus Infection in Orthotopic Liver Transplant Recipients
Last Updated: May 2, 2012
Condition(s): Hepatitis C; Liver Transplant Recipient
11
Recruiting
Telaprevir in Combination With Peginterferon and Ribavirin in Treatment-experienced Black/African American Subjects.
Last Updated: May 18, 2012
Condition(s): Hepatitis C
12
Completed
Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4
Last Updated: December 28, 2011
Condition(s): Liver Cirrhosis; Hepatitis C Virus; HIV Infection
13
Completed
Pegylated Interferon Plus Ribavirin in the Treatment of Active and Past Intravenous Drug Users Infected With Hepatitis C
Last Updated: August 3, 2011
Condition(s): Hepatitis c
14
Recruiting
A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)
Last Updated: May 18, 2012
Condition(s): Hepatitis C
15
Completed
Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice.
Last Updated: September 3, 2010
Condition(s): Hepatitis C Virus; Chronic Liver Disease; Viral Hepatitis; Therapeutic Uses; Antiviral Agents
16
Completed
Phase 2 Study of VX-950, Pegasys®, and Copegus® in Hepatitis C
Last Updated: June 22, 2011
Condition(s): Chronic Hepatitis C
17
Completed
Phase 2 Study of VX-950, Pegasys® With and Without Copegus® in Hepatitis C
Last Updated: June 22, 2011
Condition(s): Chronic Hepatitis C
18
Recruiting
Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Participants in Some Hepatitis C Virus (HCV) Trials
Last Updated: April 30, 2012
Condition(s): Hepatitis C Virus
19
Recruiting
An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients
Last Updated: May 18, 2012
Condition(s): Hepatitis C
20
Completed
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program.
Last Updated: June 1, 2010
Condition(s): Hepatitis C, Chronic

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+pegylated+interferon-alpha-2a

Page 1 of Clinical Trials for Drug pegylated interferon-alpha-2a, 510 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About